FDA Inspection 575657 — Cambrex Profarmaco Milano Srl
The FDA completed an inspection of Cambrex Profarmaco Milano Srl on March 31, 2009 in Paullo. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 31, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Paullo (Italy)